Nura Bio
4 known investors
Find your way into Nura Bio
Sign up to see every warm intro you have to Nura Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Nura Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Nura Bio develops neuroprotective medicines targeting neurological diseases by translating scientific advances in axonal degeneration and neuroimmune regulation into novel therapeutics.
Investors · 4
How we know: The Column Group's portfolio page · the company's own site · a partner's Signal profile · funding news · biospace.com · the VCSheet dataset · Not right? Tell us
How we know: Samsara BioCapital's portfolio page · funding news · biospace.com · Not right? Tell us
How we know: Sanofi Ventures's portfolio page · funding news · biospace.com · the VCSheet dataset · Not right? Tell us
Also in the syndicate · 1
Funding
SEC filings, press & company announcements$73.8M disclosed across 1 of 3 rounds · 2024–2026
- $73.8MSeries BJun 2026 · 3 sources
The Column Group (lead), Euclidean Capital, Samsara BioCapital, Sanofi Ventures
Source ↗ - Undisclosed amountSeries ASep 2024Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Nura Bio do?
- Nura Bio develops neuroprotective medicines targeting neurological diseases by translating scientific advances in axonal degeneration and neuroimmune regulation into novel therapeutics.
- Who are Nura Bio's investors?
- Nura Bio's investors include The Column Group, Samsara BioCapital, Sanofi Ventures.
- How much funding has Nura Bio raised?
- Nura Bio has disclosed $73.8M raised across 1 of its 3 known rounds.


